NetworkNewsBreaks – The Flowr Corporation (TSX.V
Post# of 65
(Total Views: 1154)
Posted On: 01/09/2019 4:04:41 PM
NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Inks Medical Cannabis Supply Agreement with Shoppers Drug Mart
The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), through its subsidiary The Flowr Group (Okanagan) Inc. (collectively “Flowr” or the company), this morning announced its entrance into an agreement with Shoppers Drug Mart, a division of Loblaw Companies Limited (TSX: L), to supply medical cannabis on a purchase order basis. Flowr will supply the leading drug store retailer with its FlowrRx brand of premium medical cannabis products. Initially, the products will be sold online only as Canadian regulations presently restrict the sale of medical cannabis in retail pharmacies, making Shoppers’ new ecommerce site the exclusive direct-to-patient online provider of FlowRx products. The term of the supply agreement is three years, with a two year renewal term. “We believe that partnering with Shoppers Drug Mart to provide patients with premium medical cannabis is a game-changing opportunity for Flowr’s medical business and we look forward to working with their team,” Flowr Co-CEO Tom Flow stated in the news release. “FlowrRx products are grown in facilities designed to pharmaceutical industry manufacturing standards and using strict processes that should enable us to provide patients with both the high quality they seek and the consistent benefits they need.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), through its subsidiary The Flowr Group (Okanagan) Inc. (collectively “Flowr” or the company), this morning announced its entrance into an agreement with Shoppers Drug Mart, a division of Loblaw Companies Limited (TSX: L), to supply medical cannabis on a purchase order basis. Flowr will supply the leading drug store retailer with its FlowrRx brand of premium medical cannabis products. Initially, the products will be sold online only as Canadian regulations presently restrict the sale of medical cannabis in retail pharmacies, making Shoppers’ new ecommerce site the exclusive direct-to-patient online provider of FlowRx products. The term of the supply agreement is three years, with a two year renewal term. “We believe that partnering with Shoppers Drug Mart to provide patients with premium medical cannabis is a game-changing opportunity for Flowr’s medical business and we look forward to working with their team,” Flowr Co-CEO Tom Flow stated in the news release. “FlowrRx products are grown in facilities designed to pharmaceutical industry manufacturing standards and using strict processes that should enable us to provide patients with both the high quality they seek and the consistent benefits they need.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)